1. Questions and answers on biosimilar development and the BPCI Act Publication: Silver Spring, MD : Center for Drug Evaluation and Research, September 2021 Subject(s): Biosimilar PharmaceuticalsDrug DevelopmentUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug AdministrationUnited States.
